United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 9, 2026 · Filed Oct 13, 2026

On Oct 9, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$544.94 for US$5.18M under a trading plan, leaving 324,443 shares. Filed Oct 13, 2026 (Form 4).

Sold
9,500 shares
Price
US$544.94 average (US$531.92 to US$550.72)
Value
US$5.18M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 9, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 9, 2026Common StockSale120US$531.92333,823Indirect
Oct 9, 2026Common StockSale320US$533.80333,503Indirect
Oct 9, 2026Common StockSale640US$534.80332,863Indirect
Oct 9, 2026Common StockSale400US$536.09332,463Indirect
Oct 9, 2026Common StockSale360US$537.05332,103Indirect
Oct 9, 2026Common StockSale400US$538.33331,703Indirect
Oct 9, 2026Common StockSale200US$539.23331,503Indirect
Oct 9, 2026Common StockSale320US$540.74331,183Indirect
Oct 9, 2026Common StockSale40US$541.51331,143Indirect
Oct 9, 2026Common StockSale240US$543.21330,903Indirect
Oct 9, 2026Common StockSale400US$544.54330,503Indirect
Oct 9, 2026Common StockSale400US$545.90330,103Indirect
Oct 9, 2026Common StockSale240US$546.60329,863Indirect
Oct 9, 2026Common StockSale878US$548.01328,985Indirect
Oct 9, 2026Common StockSale2,641US$548.93326,344Indirect
Oct 9, 2026Common StockSale1,478US$549.93324,866Indirect
Oct 9, 2026Common StockSale423US$550.72324,443Indirect

Source

View original at SEC

Related